Login / Signup

Development of a 1,3a,6a-triazapentalene derivative as a compact and thiol-specific fluorescent labeling reagent.

Atsushi NakayamaAkira OtaniTsubasa InokumaDaisuke TsujiHaruka MukaiyamaAkira NakayamaKohji ItohAkira OtakaKeiji TaninoKosuke Namba
Published in: Communications chemistry (2020)
For the fluorescence imaging of biologically active small compounds, the development of compact fluorophores that do not perturb bioactivity is required. Here we report a compact derivative of fluorescent 1,3a,6a-triazapentalenes, 2-isobutenylcarbonyl-1,3a,6a-triazapentalene (TAP-VK1), as a fluorescent labeling reagent. The reaction of TAP-VK1 with various aliphatic thiols proceeds smoothly to afford the corresponding 1,4-adducts in high yields, and nucleophiles other than thiols do not react. After the addition of thiol groups in dichloromethane, the emission maximum of TAP-VK1 shifts to a shorter wavelength and the fluorescence intensity is substantially increased. The utility of TAP-VK1 as a compact fluorescent labeling reagent is clearly demonstrated by the labeling of Captopril, which is a small molecular drug for hypertension. The successful imaging of Captopril, one of the most compact drugs, in this study demonstrates the usefulness of compact fluorophores for mechanistic studies.
Keyphrases
  • quantum dots
  • fluorescence imaging
  • living cells
  • low cost
  • blood pressure
  • single molecule
  • label free
  • high resolution
  • adverse drug
  • energy transfer
  • electronic health record
  • arterial hypertension